Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal endothelium is a specialized monolayer of hexagonal cells lining the posterior cornea, maintaining tissue clarity by regulating stromal hydration through active ion transport ("pump-leak" mechanism). It is critical for vision and especially vulnerable during surgery, trauma, aging, and disease. Its poor regenerative ability means cell loss leads to progressive corneal edema and visual impairment; therapies focus on protection, minimizing apoptosis, and promoting repair through drugs like Rho kinase inhibitors, gene therapy, and surgical technique improvements[1][2][3][4][5][6][7][8].
Promotion of endothelial cell migration and repair (Rho kinase inhibitors); Anti-apoptotic action (Bcl-xL, p35); Mechanical protection from trauma during surgery (chopper shield technique)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal endothelium protection.